BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Clinical trial NCT07062055 · RECRUITING

Trial details

NCT number: NCT07062055
Sponsor: Shandong Cancer Hospital and Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Portal Vein Tumor Thrombus Oligometastases Radiotherapy Immunotherapy Hepatic Artery Infusion Chemotherapy

Start date: 2025-07-25
Primary completion: 2028-07-25
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.